Earnings date set: Hims & Hers will release Q1 2026 results on May 11, with consensus revenue near $616M and EPS at $0.13. Novo Nordisk pact: A March settlement allows sales of brand-name GLP-1 drugs, ...
Healthcare stocks have struggled in 2026. With a year-to-date (YTD) loss of about 6%, that corner of the market has been the ...
Novo Nordisk A/S expects generic Ozempic to be delayed in China until next year, a positive step for the drugmaker as it ...
JPMorgan initiated Hims & Hers (HIMS) with Overweight and $35 target, citing Novo Nordisk (NVO) partnership as a turning point legitimizing the GLP-1 business. JPMorgan’s endorsement reframes Hims & ...
Hims & Hers Health (NYSE:HIMS) just picked up a high-profile endorsement. JPMorgan analyst Cory Carpenter initiated coverage with an Overweight rating and a $35 price target, framing the telehealth ...
Novo Nordisk will seek regulatory approval for its semaglutide pill to treat Type 2 diabetes in children and adolescents after a late-stage trial showed it significantly reduced blood sugar in 10- to ...
Him & Hers announced Thursday that eligible users can now access the full range of U.S. Food and Drug Administration (FDA)-approved GLP-1 medications on its platform. Providers can now send ...
April 22 (Reuters) - Telehealth company Hims & Hers (HIMS.N), opens new tab said on Wednesday it has a steady supply of estrogen patches and is offering them to patients through its platform, as ...
Hims & Hers (HIMS) stock surged as much as 49% in five trading sessions, with an 11% gain on Monday alone. The FDA announced a July meeting to consider easing restrictions on 12 peptides, opening a ...
Hims & Hers (HIMS) shares surged on FDA peptide tailwinds and a Novo Nordisk partnership to distribute branded Wegovy, giving the company leverage in the GLP-1 market beyond compounded alternatives.
Few telehealth stocks have generated as much momentum in a single week as Hims & Hers Health has managed to pull off recently. Shares of the company, publicly traded on the New York Stock Exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results